Key Considerations for Interpreting Scores from the PHQ-9 and GAD-7 Assessments
-
By
-
Kurt Kroenke
-
July 20, 2026
Clinical Scorecard: Key Considerations for Interpreting Scores from the PHQ-9 and GAD-7 Assessments
At a Glance
| Category | Detail |
|---|
| Condition | Depression and Anxiety |
| Key Mechanisms | Influence of instructional emphasis on symptom reporting |
| Target Population | Adults with self-reported diagnosis or treatment for major depressive disorder or generalized anxiety disorder |
| Care Setting | Psychometric research and clinical assessments |
Key Highlights
- Emphasizing 'bothered' in instructions improved PHQ-9 and GAD-7 scores.
- Study showed a 2.6-point greater reduction in scores with intervention.
- PHQ-9 and GAD-7 are core measures for depression and anxiety.
- Functional impairment and treatment desire are critical in interpreting scores.
- The PHQ-9 has strong criterion validity compared to diagnostic interviews.
Guideline-Based Recommendations
Diagnosis
- Use PHQ-9 and GAD-7 for assessing depression and anxiety severity.
Management
- Consider functional impairment and treatment desire in management strategies.
Monitoring & Follow-up
- Monitor treatment response using the PHQ-9 due to its responsiveness.
Risks
- Variability in interpretation of frequency and bothersome dimensions may affect scoring.
Patient & Prescribing Data
Adults with depression or anxiety symptoms.
Inquiring about treatment preferences can improve engagement.
Clinical Best Practices
- Incorporate questions about functional impairment and treatment desire in assessments.
- Consider replicating studies with self-completion formats to reduce bias.
Related Resources & Content
